$0.475
-0.025[-5.00%]
At close: Apr 12
$0.475
0[0.00%]
After Hours: 6:20PM EDT
Salarius Pharmaceuticals
(NASDAQ:SLRX)Salarius Pharmaceuticals Stock (NASDAQ:SLRX), Quotes and News Summary
Salarius Pharmaceuticals Stock (NASDAQ: SLRX) stock price, news, charts, stock research, profile.
| Open | $0.476 |
| Close | $0.496 |
| Volume / Avg. | 5.820K / 117.618K |
| Day Range | 0.471 - 0.496 |
| 52 Wk Range | 0.430 - 2.680 |
| Market Cap | $2.049M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 44 |
| Short Interest | 6.36% |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Salarius Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing eff...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Salarius Pharmaceuticals (SLRX) stock?
You can purchase shares of Salarius Pharmaceuticals (NASDAQ: SLRX) through any online brokerage.
Who are Salarius Pharmaceuticals's (SLRX) competitors?
Other companies in Salarius Pharmaceuticals’s space includes: Dermata Therapeutics (NASDAQ:DRMA), NeuBase Therapeutics (NASDAQ:NBSE), Bone Biologics (NASDAQ:BBLG), Quoin Pharmaceuticals (NASDAQ:QNRX) and Qualigen Therapeutics (NASDAQ:QLGN).
What is the target price for Salarius Pharmaceuticals (SLRX) stock?
The latest price target for Salarius Pharmaceuticals (NASDAQ: SLRX) was reported by HC Wainwright & Co. on Friday, March 11, 2022. The analyst firm set a price target for 4.00 expecting SLRX to rise to within 12 months (a possible 742.11% upside). 0 analyst firms have reported ratings in the last year.
Current Stock Price for Salarius Pharmaceuticals (SLRX)?
The stock price for Salarius Pharmaceuticals (NASDAQ: SLRX) is $0.475 last updated April 12, 2024 at 6:20 PM EDT.
Does Salarius Pharmaceuticals (SLRX) pay a dividend?
There are no upcoming dividends for Salarius Pharmaceuticals.
When is Salarius Pharmaceuticals (NASDAQ:SLRX) reporting earnings?
Salarius Pharmaceuticals’s Q1 earnings are confirmed for Thursday, May 9, 2024.
Is Salarius Pharmaceuticals (SLRX) going to split?
There is no upcoming split for Salarius Pharmaceuticals.
What sector and industry does Salarius Pharmaceuticals (SLRX) operate in?
Salarius Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.